Crowdonomics
This isn’t CBD Life Sciences Inc.’s most recent raise. Reg A+ · Equity · Jun 2026 (Open) is more current.View latest round
CBD Life Sciences Inc.

Reg A+ · Equity · May 2024

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $9M max
0% of ceiling
Investors
—
—
Estimated pre-money
$623.3K
—

Financials disclosed in this offering

FY2023 · hover for source
$167K
−$79K
FY2023
RevenueNet income
Metric
FY2023 audited
Income statement
Revenue
$167,147
Cost of goods sold
$86,916
Gross margin
48%
Net income
-$78,574
Balance sheet
Cash
$2,516
Accounts receivable
$175,981
Total assets
$419,327
Long-term debt
$0
Total liabilities
$24,743
Other
Headcount
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

6 amendments
  1. Mar 17, 2025
    Post-qualification amendment — offering terms unchanged
    Form 1-A POS on EDGAR ↗
  2. Mar 6, 2025
    • Maximum $1.4M → $3.6M
    • Securities offered 4,500,000,000 → 8,400,000,000
    Form 1-A POS on EDGAR ↗
  3. Sep 6, 2024
    Post-qualification amendment — offering terms unchanged
    Form 1-A POS on EDGAR ↗
  4. Aug 19, 2024
    • Maximum $10.1M → $1.4M
    Form 1-A POS on EDGAR ↗
  5. Jun 18, 2024
    • Maximum $9M → $10.1M
    • Securities offered 3,000,000,000 → 4,500,000,000
    Form 1-A/A on EDGAR ↗
  6. Jun 5, 2024
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$623.3K
Price / share$0.003
Shares offered3,000,000,000

Estimated, not stated: $0.003 × 207,769,152 securities outstanding.

Offering details

Target—
Max$9,000,000
Min investment—
OpenedMay 2, 2024
Deadline—
ClosedMay 15, 2026
Days active743

Links & provenance

Source: SEC EDGAR
0001683168-24-002931
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.